| Trademark Name/Patent Name | Application No | Date |
|---|---|---|
| Mebcacin | 3869600 | 2018-06-25 |
| Enizahex | 5475914 | 2022-06-04 |
| Mebcavir | 3869597 | 2018-06-25 |
| Enizal | 5595289 | 2022-09-03 |
| Lathipen | 5595134 | 2022-09-03 |
| Lateba | 5595287 | 2022-09-03 |
| Mejopac | 4236574 | 2019-07-16 |
| Mezomib | 3869602 | 2018-06-25 |
| Enahteb | 5655209 | 2022-10-20 |
| Narkela | 4765400 | 2020-12-02 |
| Mebatrin | 3244966 | 2016-04-27 |
| Camtin | 4614896 | 2020-08-18 |
| Elozan | 4690897 | 2020-10-07 |
| Cellyclo | 5754609 | 2023-01-07 |
| Nibdril | 5752368 | 2023-01-05 |
| Divolaxpa | 5752366 | 2023-01-05 |
| Mirdacin | 5752367 | 2023-01-05 |
| Edanib | 5098767 | 2021-08-21 |
| Edicava | 4248524 | 2019-07-27 |
| Mejotid | 3244965 | 2016-04-27 |
| Nirahep | 5595132 | 2022-09-03 |
| Sopersin | 5457236 | 2022-05-21 |
| Pacbumin | 3869603 | 2018-06-25 |
| Xeleac | 5387380 | 2022-03-28 |
| Negodac | 4660988 | 2020-09-17 |
| Vynko | 4452977 | 2020-02-25 |
| Miotepa | 4433656 | 2020-02-07 |
| Esanig | 4689180 | 2020-10-06 |
| Mebuate | 4039751 | 2018-12-28 |
| Lidomide | 4562371 | 2020-07-09 |
| Mibavirin | 3869599 | 2018-06-25 |
| Meprole | 5595131 | 2022-09-03 |
| Abiramab | 3869601 | 2018-06-25 |
| Cevilc | 5518897 | 2022-07-06 |
| Rilonavir | 3869605 | 2018-06-25 |
| Sokalt | 4562372 | 2020-07-09 |
| Prixafor | 4039748 | 2018-12-28 |
| Mirfendo | 4039747 | 2018-12-28 |
| Niglirine | 4039750 | 2018-12-28 |
| Myritinol | 4039749 | 2018-12-28 |
| Silorpy | 5752369 | 2023-01-05 |
| Menfovir | 3869604 | 2018-06-25 |
| Mejostin | 3244969 | 2016-04-27 |
| Mejophlan | 3244967 | 2016-04-27 |
| Mebiswine | 3869595 | 2018-06-25 |
| Idnatx | 4780113 | 2020-12-14 |
| Oseviral | 3869596 | 2018-06-25 |
| Mebuvir | 3244968 | 2016-04-27 |
| Nysanu | 5721605 | 2022-12-14 |
| Avnalit | 5691618 | 2022-11-21 |
| Migrethem | 5595133 | 2022-09-03 |
| Bospahen | 5533910 | 2022-07-18 |
| Naflasab | 5504106 | 2022-06-25 |
| Telamide | 4765376 | 2020-12-02 |
| Mebzila | 3869598 | 2018-06-25 |
| Gliripi | 5964453 | 2023-06-03 |
| Lecyrips | 6047697 | 2023-08-02 |
| Retoxat | 6234709 | 2023-12-26 |
| Niciret | 5456975 | 2022-05-21 |
| Caleuco | 6234710 | 2023-12-26 |
Does Mba Pharmaceuticals Private Limited owns any trademarks ?
Mebcacin, Enizahex, Mebcavir, Enizal, Lathipen, Lateba, Mejopac, Mezomib, Enahteb, Narkela, Mebatrin, Camtin, Elozan, Cellyclo, Nibdril, Divolaxpa, Mirdacin, Edanib, Edicava, Mejotid, Nirahep, Sopersin, Pacbumin, Xeleac, Negodac, Vynko, Miotepa, Esanig, Mebuate, Lidomide, Mibavirin, Meprole, Abiramab, Cevilc, Rilonavir, Sokalt, Prixafor, Mirfendo, Niglirine, Myritinol, Silorpy, Menfovir, Mejostin, Mejophlan, Mebiswine, Idnatx, Oseviral, Mebuvir, Nysanu, Avnalit, Migrethem, Bospahen, Naflasab, Telamide, Mebzila, Gliripi, Lecyrips, Retoxat, Niciret, Caleuco
Try Mr. E's contact finder tool and fetch direct mobile numbers of decision-makers of all companies globally. Grow your sales now.
Free Trial with 5 contacts. No Credit Card Required. One-click Signup.